Yuwei Yao
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The dysregulation of the immune microenvironment during endometrial intraepithelial neoplasia serves as a marker of endometrial carcinogenesis.
Journal: Frontiers in immunology
Published: November 18, 2025
Erianin facilitates pyroptosis in endometrial cancer via targeting m6A reader YTHDF1.
Journal: Chinese medicine
Published: June 12, 2025
Integrated bioinformatics and Toxicogenomics reveal bisphenol A-driven molecular networks and prognostic biomarkers in endometrial cancer.
Journal: Toxicology research
Published: June 09, 2025
Bavachinin exerts anti-tumor effects by activating TLR4/STING axis-dependent PANoptosis and synergistically enhances chemosensitivity in endometrial cancer.
Journal: Biochemical pharmacology
Published: March 17, 2025
IL-6/KIAA1429 promotes ferroptosis resistance in endometrial cancer through m6A modification of DDIT3.
Journal: Cellular signalling
Published: November 08, 2024
Engineered CAF-cancer cell hybrid membrane biomimetic dual-targeted integrated platform for multi-dimensional treatment of ovarian cancer.
Journal: Journal of nanobiotechnology
Published: October 15, 2024
Dual-Multivalent Aptamer-Based Drug Delivery Platform for Targeted SRC Silencing to Enhance Doxorubicin Sensitivity in Endometrial Cancer.
Journal: International journal of biological sciences
Published: July 17, 2024
Integrating Bioinformatics and Experimental Validation to Identify Mitochondrial Permeability Transition-Driven Necrosis-Related lncRNAs that can Serve as Prognostic Biomarkers and Therapeutic Targets in Endometrial Carcinoma.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: June 11, 2024
Ultrasound-responsive Bi2MoO6-MXene heterojunction as ferroptosis inducers for stimulating immunogenic cell death against ovarian cancer.
Journal: Journal of nanobiotechnology
Published: February 28, 2024
Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma.
Journal: Translational cancer research
Published: December 06, 2023
Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma.
Journal: Cell death discovery
Published: November 24, 2023
Characterization and validation of fatty acid metabolism-related genes predicting prognosis, immune infiltration, and drug sensitivity in endometrial cancer.
Journal: Biotechnology and applied biochemistry
Published: October 30, 2023
Last Updated: 09/26/2026